Compare

Biovie Inc. vs Actuate Therapeutics, Inc. vs CytoDyn Inc. vs Chemomab Therapeutics Ltd.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Biovie Inc. BIVI	Actuate Therapeutics, Inc. ACTU	CytoDyn Inc. CYDY	Chemomab Therapeutics Ltd. CMMB
Year ended	2026-06-30	2025-12-31	2026-05-31	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$22.07M	-$22.23M	-$42.70M	-$8.99M
EPS (Diluted)	-$3.05	-$1.06	-$0.03	$0.018
Operating cash flow	-$19.02M	-$19.21M	-$17.25M	-$11.13M
Free cash flow	n/a	n/a	n/a	-$11.13M
Cash & equivalents	$8.98M	$13.16M	$11.85M	$7.56M
Total assets	$14.25M	$14.04M	$13.97M	$13.81M
Total liabilities	$3.98M	$6.11M	$123.69M	$1.48M
Shareholders' equity	$10.27M	$7.92M	-$109.72M	$12.33M
Return on year-end equity	-214.9%	-280.5%	n/a	-72.9%
Shares outstanding	7.54M	23.25M	1.37B	n/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Biovie Inc.	Actuate Therapeutics, Inc.	CytoDyn Inc.	Chemomab Therapeutics Ltd.
Latest	n/a	n/a	$0 Ended 2023-05-31	n/a
1 year earlier	n/a	n/a	$266.0K Ended 2022-05-31	n/a
2 years earlier	n/a	n/a	$0 Ended 2021-05-31	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a